Enrichment and Expansion With Nanoscale Artificial Antigen Presenting Cells for T Cell Adoptive Immunotherapy

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-p34
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Nanoscale Artificial Antigen Presenting Cells for T Cell Immunotherapy

Nanomedicine: Nanotechnology, Biology, and Medicine
Materials ScienceMolecular MedicineNanosciencePharmaceutical ScienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2014English

Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy

Advancements in Genetic Engineering
2015English

Antigen-Specific Culture of Memory-Like CD8 T Cells for Adoptive Immunotherapy

Cancer immunology research
Cancer ResearchImmunology
2014English

Rebuilding Human Leukocyte Antigen Class II-Restricted Minor Histocompatibility Antigen Specificity in Recall Antigen-Specific T Cells by Adoptive T Cell Receptor Transfer: Implications for Adoptive Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2007English

Failed Adoptive Immunotherapy With Tumor-Specific T Cells

Cancer Research
Cancer ResearchOncology
2004English

Adoptive Cancer Immunotherapy With Human Vγ2vδ2 T Cells

English

Inhibition of AKT Signaling Uncouples T Cell Differentiation From Expansion for Receptor-Engineered Adoptive Immunotherapy

JCI insight
Medicine
2017English

Adoptive Immunotherapy of Cancer Using CD4+ T Cells

Current Opinion in Immunology
AllergyImmunology
2009English

Artificial Antigen-Presenting Cells Transduced With Telomerase Efficiently Expand Epitope-Specific, Human Leukocyte Antigen–Restricted Cytotoxic T Cells

Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy